BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3012086)

  • 1. Dog coronary artery adenosine receptor: structure of the N6-aryl subregion.
    Kusachi S; Thompson RD; Yamada N; Daly DT; Olsson RA
    J Med Chem; 1986 Jun; 29(6):989-96. PubMed ID: 3012086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dog coronary artery adenosine receptor: structure of the N6-alkyl subregion.
    Kusachi S; Thompson RD; Bugni WJ; Yamada N; Olsson RA
    J Med Chem; 1985 Nov; 28(11):1636-43. PubMed ID: 2999397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow.
    Daly JW; Padgett W; Thompson RD; Kusachi S; Bugni WJ; Olsson RA
    Biochem Pharmacol; 1986 Aug; 35(15):2467-81. PubMed ID: 3017353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationships for the N6 subregion.
    Dunwiddie TV; Worth TS; Olsson RA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):77-85. PubMed ID: 3024026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors.
    Kusachi S; Thompson RD; Olsson RA
    J Pharmacol Exp Ther; 1983 Nov; 227(2):316-21. PubMed ID: 6313897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of the N6 region of the adenosine receptor in guinea-pig ileum and rat vas deferens.
    Paton DM; Olsson RA; Thompson RT
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):313-22. PubMed ID: 2945115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxations of isolated rabbit coronary artery by purine derivatives: A2-adenosine receptors.
    Odawara S; Kurahashi K; Usui H; Taniguchi T; Fujiwara M
    J Cardiovasc Pharmacol; 1986; 8(3):567-73. PubMed ID: 2425175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
    Thompson RD; Secunda S; Daly JW; Olsson RA
    J Med Chem; 1991 Dec; 34(12):3388-90. PubMed ID: 1766003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
    Ueeda M; Thompson RD; Arroyo LH; Olsson RA
    J Med Chem; 1991 Apr; 34(4):1340-4. PubMed ID: 2016708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D; Padgett WL; Hong O; Daly JW; Daly DT; Olsson RA
    FEBS Lett; 1987 May; 215(2):203-8. PubMed ID: 3582647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-functionalized congeners of adenosine with high potency at A2-adenosine receptors: potential ligands for affinity chromatography.
    Jacobson KA; Yamada N; Kirk KL; Daly JW; Olsson RA
    Biochem Biophys Res Commun; 1986 May; 136(3):1097-102. PubMed ID: 3013167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-phenyladenosines: pronounced effect of phenyl substituents on affinity for A2 adenosine receptors.
    Kwatra MM; Leung E; Hosey MM; Green RD
    J Med Chem; 1987 May; 30(5):954-6. PubMed ID: 3572985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists.
    Niiya K; Uchida S; Tsuji T; Olsson RA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):14-9. PubMed ID: 7965706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
    Trivedi BK; Bristol JA; Bruns RF; Haleen SJ; Steffen RP
    J Med Chem; 1988 Jan; 31(1):271-3. PubMed ID: 3336027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor.
    van Galen PJ; Ijzerman AP; Soudijn W
    FEBS Lett; 1987 Oct; 223(1):197-201. PubMed ID: 2959564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the adenosine receptor in porcine coronary arteries.
    King AD; Milavec-Krizman M; Müller-Schweinitzer E
    Br J Pharmacol; 1990 Jul; 100(3):483-6. PubMed ID: 2390673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    Martin PL; Ueeda M; Olsson RA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD; Secunda S; Daly JW; Olsson RA
    J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the N6-region of the adenosine A1 receptor with computer graphics.
    Van Galen PJ; Leusen FJ; IJzerman AP; Soudijn W
    Eur J Pharmacol; 1989 Mar; 172(1):19-27. PubMed ID: 2714369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.